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Background: Despite intense investigation, the temporal sequence between alcohol consumption and mental
health remains unclear. This study explored the relationship between alcohol consumption and mental health over
multiple occasions, and compared a series of competing theoretical models to determine which best reflected the
association between the two.
Methods: Data from phases 5 (1997 to 1999), 7 (2002 to 2004), and 9 (2007 to 2009) of the Whitehall II prospective
cohort study were used, providing approximately 10 years of follow-up for 6,330 participants (73% men; mean ± SD
age 55.8 ± 6.0 years). Mental health was assessed using the Short Form (SF)-36 mental health component score.
Alcohol consumption was defined as the number of UK units of alcohol drunk per week. Four dynamic latent
change score models were compared: 1) a baseline model in which alcohol consumption and mental health
trajectories did not influence each other, 2) and model in which alcohol consumption influenced changes in mental
health but mental health exerted no effect on changes in drinking and 3) vice versa, and (4) a reciprocal model in
which both variables influenced changes in each other.
Results: The third model, in which mental health influenced changes in alcohol consumption but not vice versa,
was the best fit. In this model, the effect of previous mental health on upcoming change in alcohol consumption
was negative (γ = −0.31, 95% CI −0.52 to −0.10), meaning that those with better mental health tended to make
greater reductions (or shallower increases) in their drinking between occasions.
Conclusions: Mental health appears to be the leading indicator of change in the dynamic longitudinal relationship
between mental health and weekly alcohol consumption in this sample of middle-aged adults. In addition to
fuelling increases in alcohol consumption among low-level consumers, poor mental health may also be a
maintaining factor for heavy alcohol consumption. Future work should seek to examine whether there are critical
levels of alcohol intake at which different dynamic relationships begin to emerge between alcohol-related measures
and mental health.
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Alcohol consumption [1,2] and mental health [3-5] are
two of the biggest public health issues facing modern
society. The relationship between alcohol consumption
and mental health has been documented extensively
[6-13], and there have been several ways proposed as to
how the relationship may operate [14]. Plausible biological* Correspondence: steven.bell@ucl.ac.uk
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reproduction in any medium, provided the ormechanisms for hazardous alcohol consumption leading
to depression include alcohol reducing white and gray
matter volumes, as well as influencing neurotransmitter
functioning [15]. Changes in white and gray matter vol-
ume [16,17], and the microstructure of nerve fibers [18]
are thought to be related to major depression, while the
dysregulation of GABAergic [19,20], dopaminergic [21],
and serotonergic [22,23] systems are widely supported
hypotheses in the etiology of depression. Hazardous
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[25], lead to job loss [26], and result in other stressful
scenarios, which in turn can lead to poor mental health.
Clinical studies have also demonstrated that individuals
treated for alcohol dependence show marked decreases in
symptoms of poor mental health following a period of ab-
stinence [27] suggesting that alcohol may be the primary
causal factor. Theoretical explanations for poor mental
health influencing alcohol intake include the use of alco-
hol as a coping mechanism for tension and depression/
anxiety [28-32]. A meta-analysis of literature around the
'self-medication' hypothesis found that depression can lead
to increased alcohol consumption, and then progression to
alcohol-use disorders [33].
The current evidence base is mixed; some authors
have found that the driving force is alcohol, while others
have concluded that it is mental health. It is also hypothe-
sized that dynamic feedback cycles contribute to the escal-
ation of alcohol consumption and worsening mental health
[34]; that is, people may become depressed or anxious and
turn to alcohol, which causes them to become more de-
pressed or anxious, which eventually fuels further drinking,
or the reverse may occur, with drinking leading to symp-
toms of anxiety or depression, which encourage further
drinking. Yet, few studies have empirically tested this theory
and those that have are limited by the methods used to try
to capture the dynamic interplay between both variables
over time [35] (e.g. not taking into account repeated mea-
sures of both variables in the same model). Using repeated
longitudinal data on both alcohol consumption and mental
health symptoms would allow for hypotheses of leading in-
dicators of change (that is, alcohol consumption driving
changes in mental health, or vice versa) as well as reciprocal
relationships to be tested. Understanding the temporal
sequence of the relationship between the two processes
over time is important to public health because it will
allow for interventions/prevention strategies to be tai-
lored more effectively.
Furthermore, studies on alcohol consumption and men-
tal health have mostly been concerned with the comorbid
relationship between clinical disorders [10], not on sub-
syndrome symptoms of mental health (that is. pre-clinical
manifestations), which make up a greater proportion of the
overall burden of mental health [36] or on the drinking
habits of the general population. Previous studies have also
tended to focus on the transition or maintenance of a clin-
ical state or binary 'heavy drinker' or 'symptoms of mental
health problems' [37,9]. As the trajectory from disease free
to clinical disorder is not as simple as moving from one
state to another but is instead characterized by an escal-
ation of symptoms and behaviors, it might be argued that
other studies have failed to effectively capture the 'true'
longitudinal relationship between mental health and alco-
hol consumption. Knowing how the relationship betweenalcohol consumption and mental health operates prior
to the development of clinical disorders would allow
for primary prevention strategies to be targeted more
effectively.
The purpose of this study was therefore to address
these limitations by exploring the longitudinal relation-
ship between alcohol consumption and mental health
symptoms jointly over multiple occasions in a general
population setting, and to compare several competing
theoretical models to determine which best reflected
the association between these two factors.
Materials and methods
The Whitehall II study
The Whitehall II prospective cohort study started with a
sample of 10,308 British civil servants (6,895 men and
3,413 women), who were aged 34 to 56 years at entry
into the study (1985 to 88) [38]. The current investigation
uses of data from three clinical phases: 5 (1997 to 1999;
referred to hereafter as 'baseline'), 7 (2002 to 2004) and 9
(2007 to 2009). At baseline, the total number of eligible
participants was 7,870. Those who had not consumed alco-
hol in the year before baseline and additionally those with
missing values for either alcohol consumption or mental
health variables at baseline were excluded from the analytic
sample (n = 548 and n = 1,036 respectively; categories
were not mutually exclusive). This provided approximately
10 years of follow-up information for 6,330 participants
who had consumed alcohol in the year before baseline.
The University College London Medical School
Committee on the ethics of human research approved
the Whitehall II study.
Assessment of alcohol consumption
Participants were asked to report the number of drinks they
had consumed in the previous week, quoting separately for
beer/cider (pints), wine (glasses), and spirits (measures).
Drinks were converted into UK units of alcohol (one unit is
equivalent to 8 g of ethanol) using a conservative estimate
of one UK unit for each measure of spirits and glass of
wine, and two UK units for each pint of beer. These
converted measurements were then summed to define
the total weekly number of UK units consumed.
Assessment of mental health
Mental health (combining symptoms of depression and
anxiety) was assessed using the mental health component
score [39,40] (MCS) of the Short Form (SF)-36 question-
naire [41]. The SF-36 refers to symptoms experienced in
the previous 4 weeks. The MCS has been validated using
UK data sources [42], and reliability estimates typically
exceed values of 0.90 for Cronbach’s α [39]. The MCS
uses a scale of 0 to 100, with higher scores indicating
better functioning.
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Adjustment was made for several baseline covariates,
including age, sex, ethnicity, socioeconomic status, marital
status, highest educational qualification, economic activity,
social network [43], smoking status, level of physical activity
[44]. and use of anti-depressant medication. Problematic
alcohol consumption (defined by the CAGE questionnaire
[45]) was used to adjust for the possibility that problem
drinking may be driving any observed relationship [46].
Poor physical health could influence both alcohol
consumption [47,48] and mental health [49] trajectories.
Therefore, general physical health was accounted for by
adjusting for several chronic conditions. A combination
of self-report and validated clinical health events [50] were
included, such as self-reported long-standing physical ill-
ness and belonging to the lowest sex-specific SF-36 physical
health component quartile [51], as well as known diabetes
mellitus, coronary heart disease (CHD), stroke, transient
ischemic attack (TIA), total serum cholesterol, systolic
and diastolic blood pressure, resting heart rate over 80
beats/min [52], and body mass index (BMI).
Statistical analysis
Bivariate latent change score (LCS) models [35,53-57]
were used to explore the dominant temporal sequence
in the longitudinal relationship between alcohol con-
sumption and mental health symptoms. LCS models
are an extension of standard growth curve models [58]
(also referred to as random effects models) and acknow-
ledge that repeated measures on the same individual are
correlated. A general overview of the underlying assump-
tions and specification of LCS models are presented
(see Additional file 1), but a comprehensive outline of the
mathematical and statistical properties [55,57], as well
as a comparison of LCS models with other multivariate
longitudinal models [35] can be found elsewhere.
Briefly, there are three primary parameters of interest:
1) the slope parameter (α), which refers to the additive sum
of changes during follow-up; 2) the autoproportional param-
eter (β), which refers to the lagged effect of a variable on an
upcoming change in itself (self-feedback); and 3) the coup-
ling parameter (γ), which describes the lagged effect of one
variable on the upcoming change in the alternate variable.
Both the intercept and the slope were fitted as random
effects, allowing for them to vary between individuals. In-
tercepts and slopes (as well as their random effects) were
correlated (ρ) both within a single process (for example,
the alcohol consumption intercept with the alcohol slope)
and between processes (for example, the mental health
intercept with the alcohol slope). Intercepts and slopes
were estimated conditional on the baseline covariates
described above.
Four separate models were estimated: 1) no coupling
(baseline) model; 2) alcohol consumption producingchange in mental health model; 3) mental health
producing change in alcohol consumption model;
and 4) dynamic/reciprocal change model. Nested models
were compared to determine the best-fitting model
(that is, to justify the inclusion of either or both coupling pa-
rameters over a baseline model that did not contain them)
using a χ2 difference test.
The relative fit of the hypothesized models compared
with the observed data was assessed using the Tucker–
Lewis index (TLI), the comparative fit index (CFI), and
the root mean squared error of approximation (RMSEA).
Cut-off values close to 0.95 were used to determine a good
fit for TLI and CFI, while a cut-off value close to 0.06 was
used for RMSEA [59].
Models were estimated in Mplus v6.12 [60] using the
full information maximum likelihood (FIML) estimator
[61]. An α level of 0.05 was considered statistically sig-
nificant for all analyses.
Results
Sample composition
Table 1 displays descriptive statistics for the complete
analytic sample (based on observed information only).
The mean age of participants was 56 years, over 70% were
male, and approximately 6% were non-white. Most
were of high to intermediate socioeconomic status, almost
four-fifths were married or cohabiting, over 60% had
post-secondary or university level qualifications, and
around 65 were economically active. Almost 11% were
current smokers, 11% were identified as problem drinkers,
and 70% were physically active. In terms of physical health,
6% of the sample had known CHD, 4% had known diabetes
mellitus, 0.5% had experienced a stroke, 0.7% had ex-
perienced a TIA, almost 3% were currently being pre-
scribed anti-depressant medication, and approximately
half reported a long-standing illness.
At baseline, participants consumed on average 14.5 UK
units of alcohol per week, and this figure had reduced to
11 UK units by the end of follow-up. Mental health scores
started at an average of 51 and increased to 54 (a random
selection of observed (A) mental health and (B) alcohol
consumption trajectories are displayed in Figure 1).
Regression estimates
Indices related to model fit and statistics concerning
model comparison are shown in Table 2. All models speci-
fied were well fitting according to commonly accepted
thresholds of model fit as outlined above [59]. Detailed es-
timates for the best-fitting model are presented in Table 3,
while only the fixed effect parameters are presented for
other models specified in Table 4 (random effects for these
models can be found in Additional file 2: Table S2A).
As the association was robust to adjustment for con-
founding factors, only the fully adjusted estimates will
Table 1 Sample characteristics
n % or mean ± SD
MCS
Phase 5 6,330 51.1 ± 9.4
Phase 7 5,436 52.4 ± 8.8
Phase 9 5,195 53.8 ± 8.0
UK units of alcohol
Phase 5 6,330 14.6 ± 15.2
Phase 7 5,508 13.0 ± 13.0
Phase 9 5,215 11.1 ± 11.3
Age, years 6,330 55.8 ± 6.0
Sex
Male 4,594 72.6
Female 1,736 27.4
Total 6,330
Ethnicity
White 5,966 94.25
Non-white 364 5.75
Total 6,330
SES
High 2,852 45.3
Intermediate 2,731 43.4
Low 713 11.3
Total 6,296
Marital status
Married/cohabiting 4,861 79.6
Other 1,248 20.4
Total 6,109
Education
University 2,176 36.4
Post-secondary 1,648 27.5
Secondary 1,558 26.0
No qualifications 604 10.1
Total 5,986
Economic activity
Active 4,123 65.2
Inactive 2,203 34.8
Total 6,326
Current smoker
No 5,539 89.4
Yes 654 10.6
Total 6,193
Problem drinking (CAGE case)
No 5,531 89.0
Yes 684 11.0
Total 6,215
Table 1 Sample characteristics (Continued)
Physical activity
Active 3,405 54.16
Moderately active 1,057 16.78
Inactive 1,837 29.16
Total 6,299
Network score 6,053 7.3 ± 3.0
CHD
No 5,948 94.0
Yes 382 6.0
Total 6,330
Known diabetes
No 6,076 96.0
Yes 254 4.0
Total 6,330
Anti-depressant medication
No 6,149 97.3
Yes 171 2.7
Total 6,320
Poor self-reported physical health
No 4,821 76.2
Yes 1,509 23.8
Total 6,330
Long-standing illness
No 3,248 51.4
Yes 3,075 48.6
Total 6,323
Stroke
No 6,301 99.5
Yes 29 0.5
Total 6,330
TIA
No 6,287 99.3
Yes 43 0.7
Total 6,330
Resting heart rate > 80 bpm
No 4,969 88.15
Yes 668 11.85
Total 5,637
BMI 4,916 26.1 ± 3.9
Serum cholesterol, mmol/l 5,622 5.9 ± 1.1
Blood pressure, mmHg
Systolic 5,669 123.1 ± 16.4
Diastolic 5,669 77.6 ± 10.6
BMI, body mass index; bpm, beats per minute; CHD, coronary heart disease;
MCS, mental health component score; SES, socioeconomic status; TIA, transient
ischemic attack.
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Figure 1 Spaghetti plots of the observed longitudinal trajectories of mental health symptoms (panel A) and alcohol consumption
(panel B) in a random sample (n = 50) of participants in the Whitehall II study.
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estimates are presented). Furthermore, only parameters of
primary interest will be highlighted.
No coupling (baseline) model
The top third of Table 4 refers to the baseline model
(in which alcohol use and mental health do not influence
changes in each other). A significant autoproportional effect
for alcohol consumption was found (β = −0.42, CI −0.52
to −0.33) but not for mental health. The coefficient was
negative, indicating that those drinking more made greater
reductions in their alcohol consumption between phases.
Alcohol consumption producing change in mental health model
The middle third of Table 4 shows estimates for a model
where alcohol use affected upcoming change in mental
health, but mental health had no effect on change in al-
cohol consumption. The alcohol autoproportional effect
was significant (β = −0.43, CI −0.52 to −0.33) but not
the mental health parameter. The coupling parameter
was also non-significant. This model was compared with
the baseline model, but offered no significant improve-
ment in fit (Table 2).
Mental health producing change in alcohol consumption model
The estimates concerning the model in which mental health
scores affected upcoming change in alcohol consumption,but alcohol consumption had no effect on changes in
mental health are presented in Table 3. A significant
autoproportional effect was found for alcohol consumption
(β = −0.50, CI −0.60 to −0.40) but not mental health. The
coupling parameter was significant (γ = −0.31, CI −0.52
to −0.10) in this instance, and was negative, meaning that
those with better mental health made greater reductions
in their drinking. This model was an improvement over
the baseline model (Table 2; P < 0.01).
Dynamic/reciprocal change model
The final third of Table 4 shows estimates from a model in
which both alcohol consumption and mental health scores
are able to affect change in the alternative variable. As
in previous models, a significant autoproportional effect
was found for alcohol consumption (β = −0.50, CI −0.59
to −0.40) but not mental health. The coupling parameter
from previous phase mental health to change in alcohol
consumption remained significant (γ = −0.31, CI −0.52
to −0.11), whereas the effect of previous occasion alcohol
consumption was not associated with changes in mental
health. This model offered little improvement in fit over
the previous model (Table 2), indicating that the model in
which mental health influences changes in alcohol con-
sumption but not vice versa is the best fit to the data.
It is necessary to jointly interpret the estimates in
Table 3 to fully appreciate the dynamics of the alcohol
Table 2 Model fit indices and comparison of LCS models for total weekly alcohol consumption and mental health in
the Whitehall II study
Baseline Alcohol→ ΔMCS MCS→ Δalcohol Reciprocal
Age and sex adjusted
Fit statistics
Log likelihood −146158.161 −146158.041 −146155.151 −146154.760
χ2 (df) 274.233 (12) 273.995 (11) 268.214 (11) 267.432 (10)
RMSEA 0.059 0.061 0.061 0.064
AIC 292380.321 292382.083 292376.302 292377.520
SSA BIC 292494.731 292500.068 292494.288 292499.081
CFI 0.982 0.982 0.982 0.982
TLI 0.959 0.955 0.956 0.952
Model comparison (difference in χ2 fit (df))
Versus baseline – 0.238 (1), P = 0.63 6.019 (1), P = 0.01 6.801 (2), P = 0.03
Versus previous best – – – 0.782 (1), P = 0.38
Fully adjusted
Fit statistics
Log likelihood −243989.314 −243989.108 −243985.355 −243984.851
χ2 (df) 328.239 (54) 327.827 (53) 320.320 (53) 319.312 (52)
RMSEA 0.028 0.029 0.028 0.028
AIC 488798.629 488800.217 488792.710 488793.702
SSA BIC 490264.509 490269.672 490262.165 490266.732
CFI 0.983 0.983 0.984 0.984
TLI 0.952 0.951 0.953 0.952
Model comparison (difference in χ2 fit (df))
Versus baseline – 0.412 (1), P = 0.52 7.919 (1), P < 0.01 8.927 (2), P < 0.01
Versus previous best – – – 1.008 (1), P = 0.32
AIC, Akaike information criterion; CFI, comparative fit index; df, degrees of freedom; LCS, latent change score; MCS, mental health component score; RMSEA, root
mean square error of approximation; SSA BIC, sample size adjusted Bayesian information criterion; TLI, Tucker-Lewis index.
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dependent on each other [54,55,57,62]. Concentrating on
the fully adjusted estimates, to predict change, Equation 4
in Additional file 1 would be adapted to remove the coup-
ling parameter from previous phase alcohol consumption
to changes in mental health, resulting in a final change
equation (conditional on other covariates in the model; for
coefficients, see Additional file 3: Table S3A) of:
ΔAlcoholit ¼ 23:31 4:86−0:50 Alcoholit−1
−0:31MCSit−1
ΔMCSit ¼ 7:20 1:37−0:11MCSit−1
The expected change in both mental health scores and
UK units of alcohol consumed between phases can then
be plotted within a vector field [63] (Figure 2). This figure
displays the direction and magnitude of change in both var-
iables for a given set of starting co-ordinates. The ellipsoid
reflects where 95% of the data lay.Discussion
Summary and interpretation of findings
A series of LCS models were estimated to test lag-leading
and reciprocal relationships between weekly number of
UK units consumed and mental health. In both minimally
adjusted and fully adjusted models, it was found that a
model in which mental health was specified as the leading
indicator of change gave the best fit (Table 2, Table 3).
Plotting the parameters of this model in a vector field
(Figure 2) demonstrates the complex relationship between
weekly alcohol consumption and mental health, and also
helps to visualize the correlation between the mental health
intercept and alcohol slope, which is difficult to interpret in
isolation. It shows that participants who initially had poor
mental health and low alcohol consumption increased their
consumption between phases, whereas those with good to
adequate mental health who drank at higher levels tended
to decrease their consumption between phases while their
mental health scores remained relatively stable. Further-
more, it shows that participants with poor mental health
Table 3 Parameter estimates (95% confidence intervals) for the best-fitting LCS model of weekly alcohol consumption
and mental health symptoms in the Whitehall II studya (MCS→ Δalcohol model)
MCS→ Δ alcohol model Age and sex adjusted Fully adjustedb
Alcohol MCS Alcohol MCS
Fixed effects
Intercept 17.11 (16.69 to 17.53) 51.54*** (51.28 to 51.79) 17.58 (16.64 to18.52) 53.41*** (52.81 to 54.00)
Slope (α) 21.46** (8.50 to 34.43) 4.96 (−8.62 to 18.54) 23.31*** (11.00 to 35.62) 7.20 (−5.55 to 19.96)
Autoproportional (β) −0.50*** (−0.61 to −0.40) −0.07 (−0.33 to 0.19) −0.50*** (−0.60 to −0.41) −0.11 (−0.35 to 0.12)
Coupling (γ) – −0.30* (−0.53 to −0.06) – −0.31** (−0.52 to −0.10)
Random effects
Residual variance 35.77*** (34.23 to 37.3) 35.02*** (33.51 to 36.54) 35.77*** (34.25 to 37.29) 34.94*** (33.45 to 36.42)
Intercept variance 177.95*** (170.31 to 185.58) 46.91*** (43.70 to 50.11) 144.21*** (137.72 to 150.71) 39.66*** (36.75 to 42.58)
Slope variance 26.26*** (12.55 to 39.98) 2.31*** (1.27 to 3.34) 23.66*** (12.24 to 35.08) 1.88** (0.81 to 2.95)
Intercept/slope correlation 0.69*** −0.30 0.67*** −0.12
Intercepts correlation −0.02 0.02
Slopes correlation −0.11 −0.02
Alcohol intercept, MCS
slope correlation
−0.05 −0.06
LCS, latent change score; MCS, mental health component score.
*** P < 0.001; ** P < 0.01; * P < 0.05.
an = 6,330.
bFully adjusted = age (centered around the sample mean), sex (male referent group), ethnicity (white (referent) versus non-white), socioeconomic status (defined
by most recent recorded employment grade – entered as a linear term with high (referent), intermediate and low categories), marital status (married/cohabiting
(referent) versus other), highest educational qualification (University (referent), post-secondary, secondary or no qualifications – entered as a continuous variable),
economic activity (active (referent) versus inactive (merging retired and unemployed groups together)), social network (centered around the mean score), current
smoking status (no (referent) versus yes), level of physical activity (active (referent), moderately active or low – entered as a linear term), CAGE caseness (no case
(referent) versus case), use of anti-depressant medication was also controlled for (no (referent) versus current), self-reported long-standing physical illness (no (referent)
versus yes), belonging to the lowest sex-specific SF-36 physical health component quartile (no (referent) versus yes), known diabetes (no (referent) versus yes), coronary
heart disease (no (referent) versus yes), stroke (no (referent) versus yes), transient ischemic attack (no (referent) versus yes), total serum cholesterol (centered around the
sample mean), systolic and diastolic blood pressure (centered around their mean values), a resting heart rate > 80 beats/minute (no (referent) versus yes) and body mass
index (centered around the sample mean).
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had a shallower decline in their consumption than those
with good mental health drinking the same amount.
This indicates that in addition to fuelling increases in
alcohol consumption among low-level consumers, poor
mental health may also be a maintaining factor for heavy
alcohol consumption.
Comparison with other work
Our findings contradict the most recently published re-
view on the relationship between alcohol use and depres-
sion [10], which concluded that increasing involvement
with alcohol raises the risk of depression by two-fold. This
review was, however, met with criticism [64,65] for pri-
marily being based on previous work by the authors them-
selves [9]. Furthermore, the review focused on alcohol-use
disorders and major depression. Our work is therefore not
directly comparable. As outlined earlier, we chose to focus
on sub-syndrome symptoms of mental health and alcohol
consumption (not problem consumption) as there has been
a distinct lack of work exploring actual alcohol consumption
(that is, what people drink) in this relationship; previous
interest has largely been on the relationship betweenalcohol-use disorders and major depression. This makes
drawing comparisons between our work and others compli-
cated. It may be that there is something about the symp-
toms of problematic alcohol consumption that increases
the risk of having [6,7,66-71] or developing [9,10,72,73]
depression, independent of the amount of alcohol con-
sumed [46,74]. Recent work has shown that individuals
who self-medicate symptoms of anxiety [75] or depression
[12] with alcohol have an increased risk of developing
(persistent) alcohol dependence. Therefore, it could be
that the relationship we observed is part of a larger
complex system involving a transition from sub-syndromal
symptoms of mental health influencing changes in alcohol
consumption (as in our analyses) until a certain threshold
is reached, at which symptoms of alcohol dependence take
over and increase the risk of developing clinical disorders
[9,10]; that is, there are two separate dynamic systems at
play that influence alcohol consumption and mental health
pre and post clinical disorder.
Strengths and weaknesses
The approach that we took to modeling the relationship
between alcohol use and mental health longitudinally
Table 4 Fixed effect parameter estimates (95% confidence intervals) for other LCS model specifications of weekly
alcohol consumption and mental health symptoms in the Whitehall II studya
Age and sex adjusted Fully adjustedb
Alcohol MCS Alcohol MCS
Baseline
Intercept 17.15*** (16.73 to 17.57) 51.57*** (51.31 to 51.82) 17.63*** (16.69 to 18.57) 53.46*** (52.86 to 54.05)
Slope (α) 4.82*** (3.26 to 6.39) 5.34 (−8.16 to 18.85) 5.22*** (3.56 to 6.89) 7.77 (−4.69 to 20.24)
Autoproportional (β) −0.43*** (−0.53 to −0.33) −0.08 (−0.34 to 0.18) −0.42*** (−0.52 to −0.33) −0.12 (−0.36 to 0.11)
Coupling (γ) – – – –
Alcohol→ ΔMCS model
Intercept 17.15*** (16.73 to 17.57) 51.57*** (51.31 to 51.83) 17.63*** (16.7 to 18.57) 53.47*** (52.87 to 54.06)
Slope (α) 4.83*** (3.26 to 6.39) 7.86 (−8.21 to 23.94) 5.23*** (3.56 to 6.89) 10.82 (−3.90 to 25.55)
Autoproportional (β) −0.43*** (−0.53 to −0.33) −0.12 (−0.41 to 0.17) −0.43*** (−0.52 to −0.33) −0.17 (−0.42 to 0.09)
Coupling (γ) −0.03 (−0.15 to 0.09) – −0.04 (−0.15 to 0.08) –
Reciprocal Δ model
Intercept 17.11*** (16.69 to 17.54) 51.55*** (51.29 to 51.81) 17.59*** (16.65 to 18.53) 53.42*** (52.83 to 54.02)
Slope (α) 21.49** (9.07 to 33.92) 8.72 (−6.03 to 23.47) 23.20*** (11.42 to 34.99) 11.05 (−2.70 to 24.79)
Autoproportional (β) −0.50*** (−0.60 to −0.40) −0.13 (−0.40 to 0.14) −0.50*** (−0.59 to −0.40) −0.17 (−0.41 to 0.08)
Coupling (γ) −0.05 (−0.16 to 0.06) −0.30** (−0.52 to −0.07) −0.06 (−0.16 to 0.05) −0.31** (−0.52 to −0.11)
LCS, latent change score; MCS, mental health component score.
*** P < 0.001; ** P < 0.01; * P < 0.05.
an = 6,330.
bFully adjusted = age (centered around the sample mean), sex (male referent group), ethnicity (white (referent) versus non-white), socioeconomic status (defined
by most recent recorded employment grade – entered as a linear term with high (referent), intermediate and low categories), marital status (married/cohabiting
(referent) versus other), highest educational qualification (University (referent), post-secondary, secondary or no qualifications – entered as a continuous variable),
economic activity (active (referent) versus inactive (merging retired and unemployed groups together)), social network (centered around the mean score), current
smoking status (no (referent) versus yes), level of physical activity (active (referent), moderately active or low – entered as a linear term), CAGE caseness (no case
(referent) versus case), use of anti-depressant medication was also controlled for (no (referent) versus current), self-reported long-standing physical illness (no (referent)
versus yes), belonging to the lowest sex-specific SF-36 physical health component quartile (no (referent) versus yes), known diabetes (no (referent) versus yes), coronary
heart disease (no (referent) versus yes), stroke (no (referent) versus yes), transient ischemic attack (no (referent) versus yes), total serum cholesterol (centered around the
sample mean), systolic and diastolic blood pressure (centered around their mean values), a resting heart rate > 80 beats per minute (no (referent) versus yes) and body
mass index (centered around the sample mean).
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in both variables over time, which is known to improve
the accuracy of estimated change [58,76]. Previous work
has also shown that it is important to consider variability
in alcohol consumption [77], and the LCS model method-
ology directly incorporated individual change both in the
total weekly alcohol consumption and in mental health.
Furthermore, the method we used allowed for the effect of
alcohol consumption on mental health and vice versa to
be estimated simultaneously in the same model.
There are, however, several limitations of our study. First,
data from phase 5 were used as the starting point, and it is
possible that selective attrition may have occurred between
the 'true' baseline (phase 1) and the baseline used in these
analyses. This would result in a healthier cohort of partici-
pants being used to estimate the final model parameters,
reducing the generalizability of the findings [78,79]. Simi-
larly, we used data from the Whitehall II cohort of British
civil servants, which is not a representative sample of the
general population. Work published using Whitehall II
data has been highly influential in epidemiology and pub-
lic health, shaping research agendas on social inequalitiesin health [80] and improving the understanding of the
etiology of disease [81] but this limitation should be noted
when considering the generalizability of our findings.
Second, one of the major concerns in alcohol epi-
demiology is measurement error in self-reported alcohol
consumption [82]. It is acknowledged that self-reported
measures of consumption are likely to be biased [82-88],
and therefore effect estimates obtained may actually be
underestimates of the true association of interest. The use
of latent variables (upon which LCS models are based; see
Additional file 1) has been advocated in the field of alcohol
epidemiology [89] to account for this known measurement
error. Additionally, the MCS scale of the SF-36 is not solely
concerned with psychiatric symptoms but also with mental
health-related quality of life (although evidence exists
to suggest that high MCS scores are associated with
clinical depression [40,90,91]). It is possible that the
relationship between alcohol intake and mental health
might differ if other psychiatric questionnaires were
used to define symptoms of mental health, or if the dis-
tinction was made between symptoms of depression
and anxiety. However, it is argued that in practice it is
Figure 2 Vector field showing joint movements between weekly alcohol consumption and mental health scores in Whitehall II as a
function of the mental health producing change in weekly alcohol consumption system. Ellipsoid reflects 95% of the data.
Bell and Britton BMC Medicine 2014, 12:91 Page 9 of 13
http://www.biomedcentral.com/1741-7015/12/91difficult to effectively determine specific characteristics
of depression from symptoms of, for example, anxiety
using self-report measures of symptoms because of the
considerable heterogeneity of symptoms between disorders
(that is, self-reported symptoms often reflect a comorbidity
between depression and other mood/stress-related disor-
ders [92-95]). This has led some investigators to conclude
that self-report measures of mental health symptoms at a
population level merely reflect a single underlying latent
construct of psychological distress [96-99].
Another issue concerning the main measures used in
this study is that they refer to different time periods;
information on alcohol consumption pertained to the
previous week whereas information on mental health
symptoms referred to the previous 4 weeks. It is possible
that this discrepancy in the period of reference may have
biased our findings. For example, smaller studies looking
at the relationship between mood and alcohol on a daily
basis have shown that increased alcohol consumption is
associated with decreased happiness on the following day,
and that symptoms of sadness are associated with de-
creased consumption on the next day [100]. These
findings contrast with our own, and highlight the
importance of the timeframe used in determining the
best-fitting temporal sequence between alcohol consump-
tion and mental health.Furthermore, the competing models we specified allowed
only for the previous occasion's alcohol and/or mental
health score to influence change in the alternative variable
by the next occasion. It is plausible that the relationship
might have differed if we had allowed for longer lag
specifications, as it may be that the relationship between
alcohol intake and mental health takes longer to manifest
(that is, the current specification of a single cross-lagged
effect may fit the relationship between mental health influ-
encing alcohol intake better than the relationship between
alcohol consumption influencing mental health symptoms).
Additionally, there was greater variation in the measure
of weekly alcohol intake than in that of mental health.
It could be argued that this could also be a possible ex-
planation as to why alcohol consumption was not
found to be significantly related to changes in mental
health. It may be that within a dynamic system that it
is more difficult to effectively predict changes in one
variable using a highly erratic alternative exposure. It is
conceivable that the reciprocal model might have been of
best fit had both measures been relatively stable over time.
A further methodological limitation is that we controlled
only for baseline covariate values, and it is possible that
their values changed over time. For example, comorbidities
may have developed after the first measurement occasion.
Health behaviors such as physical activity and smoking
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variables could all be confounders of the subsequent effects
of alcohol on mental health and vice versa. However,
factoring in changes in the covariate structure over time
could be problematic within the current framework,
because changes in some values, for example, systolic blood
pressure, could be a direct consequence of previous alcohol
consumption or mental health status, and thus be consid-
ered as intermediate confounders [101].
Implications and directions for future work
We identified that the dominant process underlying the
dynamic relationship between alcohol consumption and
mental health at a population level is mental health.
Consequently, it could be inferred that targeting inter-
ventions to those with poor mental health (as well as
introducing measures to ensure that those with normal/
good mental health do not deteriorate) would have a
beneficial effect in terms of reducing heavy drinking.
This may also elicit favorable knock-on effects in terms of
improving general physical health and reducing the risk of
chronic diseases, as heavy drinking itself is associated with
an increased risk of a range of health problems [102,103]
including cardiovascular disease [104-109], cancer, [110,111]
and mortality [47,112-114]. Furthermore, the finding
that mental health affects alcohol consumption may
shed some light on the growing literature examining
common mental disorders as risk factors for cardiovascu-
lar disease [115-119] and all-cause mortality [120-122],
because alcohol consumption may be one of many me-
diators in this relationship.
This work provides further support that on-going ef-
forts to improve mental health at a population level are
vital to public health [123,124]. The proposed imple-
mentation strategy [124] seeks both to tackle he social
determinants of mental health [125] and to target indi-
viduals who are at high risk. To do so, a number of ave-
nues will be pursued, including tackling inequalities in
access to services (and ensuring equality in the level of
service provided). In addition, conscious efforts are be-
ing made to tackle the stigma surrounding mental
health issues; perhaps if individuals feel more com-
fortable talking about their mental health problems or
seeking treatment for them, then they will not turn to
alcohol as a form of self-medication.
Others may, however, be more cynical of our findings
and take them to indicate that 1) consuming large amounts
of alcohol is acceptable as it does not increase the risk
of developing mental health problems, and 2) that it is
reasonable to self-medicate with alcohol in response to
psychological distress, as it will not worsen symptoms.
However, it would be unwise to use our findings as a
justification for drinking in a hazardous manner. Although
a person’s mental health may not worsen, as highlightedabove, increased alcohol consumption would heighten their
risk of developing other disorders.
Regarding future work, it is important to examine the
role of drinking pattern as well as to provide closer
scrutiny of age (e.g. adolescent and elderly populations),
sex, socioeconomic, and cultural differences in the dy-
namic relationship between alcohol consumption and
mental health. It is also important that subsequent studies
should examine the extent to which time-varying/modified
confounding may explain the association observed using
appropriate analytic methods [101]. Furthermore, it is also
imperative that potential physiological and psychosocial
mechanisms, both occurring alongside and precipitating
(immediately or earlier in life) the parallel development of
both trajectories are studied. This has been acknowledged
by others in the field [10,64,65]. Understanding the factors
that trigger increased alcohol consumption in the pres-
ence of poor mental health will allow for more effective
interventions to be developed, both in terms of treatment
and primary prevention.
Conclusions
Mental health appears to be the leading indicator of change
in the dynamic longitudinal relationship between mental
health and weekly alcohol consumption in this middle-
aged, mostly white, male, and well-educated sample of
individuals. In addition to increasing alcohol intake among
low-level consumers, poor mental health may also be a
maintaining factor for sustained high alcohol intake in
heavy alcohol consumers. Our findings therefore indicate
that on-going efforts to improve mental health at a popula-
tion level may also help to reduce hazardous alcohol con-
sumption. Future work should seek to examine whether
there are critical levels of alcohol consumption at which
different dynamic relationships operate between alcohol-
related behavior and mental health, specifically focusing on
heterogeneities in the dynamic processes between alcohol
intake and symptoms of alcohol dependence, and mental
health pre and post clinical disorder to try and better
capture the possible discontinuous progression from sub-
syndrome behavior to clinically relevant outcomes.
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